[Prevalence of neurological complications in Japanese patients with AIDS after the introduction of HAART].
We investigated trends in neurological complications of infection with human immunodeficiency virus (HIV) in Japan after the introduction of highly active antiretroviral therapy (HAART). Two questionnaire surveys were performed in hospitals treating acquired immunodeficiency syndrome (AIDS) to compare two periods: immediately after the introduction of HAART (1999-2001); and a few years later (2002-3). Neurological complications accompanied 15.9% in 1999-2001 and 9.8% in 2002-3. Neurological complications developed without HAART in about 80% of cases. Neurological complications developed as the first AIDS-defining disease for 8.3% of AIDS patients in 1999-2001 and for 5.4% in 2002-3. Prevalences of HIV encephalopathy and myelopathy decreased markedly over the study period, as reported in other developed nations. However, prevalences of cytomegalovirus encephalitis, PML and primary brain lymphoma did not decrease. PML and primary brain lymphoma occurred in patients who received HAART and whose CD4 counts were relatively high during the study period. This is probably related to the extended survival of HIV-infected individuals after the introduction of HAART as a worldwide therapy, and the reactivation of viremia or latent infection persisting within the central nervous system.
Yoritaka
Asako
A
Department of Neurology, Tokyo Metropolitan Komagome Hospital, Japan.
Ohta
Keiko
K
Kishida
Shuji
S
D020943:AIDS Arteritis, Central Nervous System / Q000453:epidemiology; D016263:AIDS-Associated Nephropathy / Q000453:epidemiology; D000386:AIDS-Related Complex / Q000453:epidemiology; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000188:drug therapy*; D023241:Antiretroviral Therapy, Highly Active; D002493:Central Nervous System Diseases / Q000453:epidemiology*; D006801:Humans; D007564:Japan / Q000453:epidemiology; D015995:Prevalence; D011795:Surveys and Questionnaires